3 results
Approved WMOCompleted
The primary objective is to evaluate the safety of ReFacto AF in previously untreated patients (no prior exposure to factor products or any blood products) of less than 6 years of age.
Approved WMOCompleted
To characterize the single-dose pharmacokinetic (PK) of RPV after SC administration of RPV LA suspensions with different doses and/or different particle size (PS) to support further dose and formulation selection, in healthy adult participants.To…
Approved WMOPending
The objective of this study is to find out whether women with OSA treated with Autoset For Her experience a greater improvement in sleep-related problems compared to the Autoset standard.We also want to investigate whether the pressure is higher…